We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
+$276M
(+19%)
Cap. Flow
+$178M
Cap. Flow
% of AUM
10.22%
Top 10 Holdings %
Top 10 Hldgs %
26.57%
Holding
376
New
39
Increased
143
Reduced
134
Closed
9
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Equity ETF
DFUS
|
+$53.3M |
| 2 |
U.S. Targeted Value Portfolio ETF Class Shares
DFAT
|
+$48.6M |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$28.7M |
| 4 |
U.S. Small Cap Portfolio ETF Class Shares
DFAS
|
+$28.3M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.93M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$1.82M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
| 4 |
The Marzetti Company
MZTI
|
+$1.18M |
| 5 |
iShares Micro-Cap ETF
IWC
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 31.47% |
| 2 | Technology | 15.8% |
| 3 | Financials | 10.71% |
| 4 | Healthcare | 10.19% |
| 5 | Consumer Staples | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Organon & Co
OGN
$3.62B
| $311K | 0.02% |
+10,265
| New | +$338K |
2021 Q2
0 quarters
|
|
302
Broadstone Net Lease
BNL
$3.49B
| $309K | 0.02% |
+13,216
| New | +$284K |
2021 Q2
0 quarters
|
|
303
Schwab US Mid-Cap ETF
SCHM
$14.4B
| $309K | 0.02% |
11,841
+105
| +0.9% | +$2.71K |
2021 Q1
1 quarter
|
|
304
VanEck Gold Miners ETF
GDX
$26.1B
| $307K | 0.02% |
9,025
| – | – |
2020 Q2
4 quarters
|
|
305
Intercontinental Exchange
ICE
$89.1B
| $306K | 0.02% |
2,577
+101
| +4% | +$11.6K |
2020 Q2
4 quarters
|
|
306
Ross Stores
ROST
$75.7B
| $303K | 0.02% |
+2,447
| New | +$305K |
2021 Q2
0 quarters
|
|
307
iShares Gold Trust
IAU
$61.6B
| $301K | 0.02% |
8,937
| – | – |
2019 Q3
7 quarters
|
|
|
VJET
308
Flyte Aviation, Inc.
VJET
$1.77M
| $299K | 0.02% |
1
| – | – |
2021 Q1
1 quarter
|
|
309
Manulife Financial
MFC
$72.8B
| $297K | 0.02% |
15,081
+143
| +1% | +$3K |
2021 Q1
1 quarter
|
|
310
State Street Health Care Select Sector SPDR ETF
XLV
$45.8B
| $290K | 0.02% |
2,303
-76
| -3% | -$9.31K |
2017 Q2
16 quarters
|
|
311
Viatris
VTRS
$21.2B
| $289K | 0.02% |
20,211
-1,745
| -8% | -$25.2K |
2020 Q4
2 quarters
|
|
312
Fifth Third Bancorp
FITB
$45.8B
| $288K | 0.02% |
7,526
| – | – |
2020 Q4
2 quarters
|
|
313
Eterna Therapeutics
ERNA
$2.38M
| $285K | 0.02% |
+2
| New | +$288K |
2021 Q2
0 quarters
|
|
314
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.3B
| $285K | 0.02% |
3,516
-396
| -10% | -$31.8K |
2017 Q1
17 quarters
|
|
315
iShares US Healthcare ETF
IYH
$4.18B
| $284K | 0.02% |
5,200
-325
| -6% | -$17.2K |
2018 Q4
10 quarters
|
|
316
Marsh
MRSH
$89.7B
| $280K | 0.02% |
+1,992
| New | +$267K |
2021 Q2
0 quarters
|
|
317
iShares Core US Aggregate Bond ETF
AGG
$138B
| $275K | 0.02% |
2,384
| – | – |
2019 Q4
6 quarters
|
|
318
Waste Management
WM
$89.7B
| $274K | 0.02% |
+1,953
| New | +$270K |
2021 Q2
0 quarters
|
|
319
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $273K | 0.02% |
+5,147
| New | +$266K |
2021 Q2
0 quarters
|
|
320
iShares S&P 500 Value ETF
IVE
$49.9B
| $270K | 0.02% |
1,830
-224
| -11% | -$33K |
2020 Q4
2 quarters
|
|
321
Petrobras
PBR
$166B
| $269K | 0.02% |
22,000
| – | – |
2020 Q4
2 quarters
|
|
|
TCON
322
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $263K | 0.02% |
2,023
| – | – |
2020 Q1
5 quarters
|
|
323
Ecolab
ECL
$81.1B
| $258K | 0.01% |
1,251
-120
| -9% | -$26.1K |
2020 Q2
4 quarters
|
|
324
EOG Resources
EOG
$82.3B
| $258K | 0.01% |
3,087
-125
| -4% | -$9.89K |
2021 Q1
1 quarter
|
|
325
S&P Global
SPGI
$126B
| $252K | 0.01% |
615
| – | – |
2021 Q1
1 quarter
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2021 Portfolio in Review
As of Q2 2021, Dowling & Yahnke held 376 positions worth $1.74B, up 19% from $1.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Dowling & Yahnke deployed $178M of net new capital in Q2 2021, opening 39 new positions and adding to 143 existing holdings. Its largest new stake was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Bank of America, an estimated $1.93M trimmed.
- Dowling & Yahnke's largest Q2 2021 buy was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
- Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $5.26M increase.
- Dowling & Yahnke's biggest Q2 2021 reduction was Bank of America, cutting an estimated $1.93M.
- Dowling & Yahnke fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.82M.
- Dowling & Yahnke's ten largest holdings make up 27% of its $1.74B portfolio in Q2 2021.
- Dowling & Yahnke opened 39 new positions and closed 9 in Q2 2021.
- Dowling & Yahnke's portfolio value rose 19% quarter-over-quarter to $1.74B.
Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.